ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Santen Pharmaceutical Company (PK)

Santen Pharmaceutical Company (PK) (SNPHY)

10,0435
-0,1165
(-1,15%)
Fermé 06 Janvier 10:00PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
10,0435
Prix Achat
9,64
Prix Vente
10,43
Volume échangé
2 583
10,01 Fourchette du Jour 10,50
8,95 Plage de 52 semaines 13,00
Cap du marché
Clôture Veille
10,16
Ouverture
10,50
Dernière Transaction
539
@
10.0435
Dernière heure de transaction
Volume financier
US$ 26 403
VWAP
10,2218
Volume moyen (3 m)
9 476
Actions en circulation
363 996 254
Rendement du Dividende
1.13%
Ratio Cours sur Bénéfices
0,14
Bénéfice par action (BPA)
73,36
Chiffre d'affairess
302,65B
Bénéfice net
26,7B

À propos de Santen Pharmaceutical Company (PK)

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Diversified
Site Web
Siège social
Higashiosaka, Osaka, Jpn
Fondé
1984
Santen Pharmaceutical Company (PK) est coté dans le secteur Pharmaceutical Preparations de la OTCMarkets avec le ticker SNPHY. Le dernier cours de clôture d'Santen Pharmaceutical (PK) était de US$10,16. Au cours de la dernière année, les actions de Santen Pharmaceutical (PK) ont été négociées dans une fourchette de prix de US$ 8,95 à US$ 13,00.

Santen Pharmaceutical (PK) compte actuellement 363 996 254 actions en circulation. La capitalisation boursière d'Santen Pharmaceutical (PK) est de US$3,70 milliard. Santen Pharmaceutical (PK) a un ratio cours/bénéfice (ratio PE) de 0.14.

SNPHY Dernières nouvelles

Parion Sciences Announces Exclusive Option Agreement for the Development and Commercialization of P-321 in Ophthalmology in C...

Parion Sciences Announces Exclusive Option Agreement for the Development and Commercialization of P-321 in Ophthalmology in Certain Asian Territories -- Parion has a plan for the first clinical...

Santen and TRACON Announce Agreement for the Development and Commercialization of TRC105 in Ophthalmology

Santen and TRACON Announce Agreement for the Development and Commercialization of TRC105 in Ophthalmology PR Newswire SAN DIEGO and OSAKA, Japan, March 4, 2014 SAN DIEGO and OSAKA, Japan, March...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.2565-2.4902912621410.310.6159.252038410.00499221DR
4-1.2815-11.315673289211.32512.159.251978310.29561269DR
12-2.3565-19.004032258112.412.959.25947610.52611456DR
26-0.3465-3.3349374398510.39139.251000911.21312592DR
520.31653.253829546629.727138.95753310.86987745DR
156-2.2365-18.212540716612.28136.2282539.18423151DR
260-8.6265-46.205141938918.6720.936.23291512.05980232DR

SNPHY - Frequently Asked Questions (FAQ)

What is the current Santen Pharmaceutical (PK) share price?
The current share price of Santen Pharmaceutical (PK) is US$ 10,0435
How many Santen Pharmaceutical (PK) shares are in issue?
Santen Pharmaceutical (PK) has 363 996 254 shares in issue
What is the market cap of Santen Pharmaceutical (PK)?
The market capitalisation of Santen Pharmaceutical (PK) is USD 3,7B
What is the 1 year trading range for Santen Pharmaceutical (PK) share price?
Santen Pharmaceutical (PK) has traded in the range of US$ 8,95 to US$ 13,00 during the past year
What is the PE ratio of Santen Pharmaceutical (PK)?
The price to earnings ratio of Santen Pharmaceutical (PK) is 0,14
What is the cash to sales ratio of Santen Pharmaceutical (PK)?
The cash to sales ratio of Santen Pharmaceutical (PK) is 0,01
What is the reporting currency for Santen Pharmaceutical (PK)?
Santen Pharmaceutical (PK) reports financial results in JPY
What is the latest annual turnover for Santen Pharmaceutical (PK)?
The latest annual turnover of Santen Pharmaceutical (PK) is JPY 302,65B
What is the latest annual profit for Santen Pharmaceutical (PK)?
The latest annual profit of Santen Pharmaceutical (PK) is JPY 26,7B
What is the registered address of Santen Pharmaceutical (PK)?
The registered address for Santen Pharmaceutical (PK) is 4-20 OFUKA TOWN, KITA-KU, OSAKA PREFECTURE, HIGASHIOSAKA, OSAKA, 533-8651
What is the Santen Pharmaceutical (PK) website address?
The website address for Santen Pharmaceutical (PK) is www.santen.co.jp
Which industry sector does Santen Pharmaceutical (PK) operate in?
Santen Pharmaceutical (PK) operates in the PHARMACEUTICAL DIVERSIFIED sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
EGIOQEdgio Inc (CE)
US$ 0,01
(999 900,00%)
584
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0,008
(799 900,00%)
477
THCBFTHC Biomed International Limited (CE)
US$ 0,001
(99 900,00%)
100
AEORFAEON REIT Investment Corporation (PK)
US$ 796,08
(26 436,00%)
1
EFTReFFECTOR Therapeutics Inc (CE)
US$ 0,0002
(19 900,00%)
225
UFABQUnique Fabricating Inc (CE)
US$ 0,000001
(-99,98%)
102,53k
VICFFVice Health and Wellness Inc (CE)
US$ 0,000001
(-99,97%)
996
SAFSSafer Shot Inc (CE)
US$ 0,000001
(-99,93%)
2,54M
ERFBERF Wireless Inc (CE)
US$ 0,0001
(-99,89%)
99,77k
ARVLFArrival (CE)
US$ 0,0002
(-99,60%)
42,86k
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,0038
(52,00%)
608,97M
HMBLHUMBL Inc (PK)
US$ 0,0009
(0,00%)
546,25M
PHILPHI Group Inc (PK)
US$ 0,0003
(0,00%)
501,07M
CBIACanopus Biopharma Inc (PK)
US$ 0,0002
(100,00%)
281,95M
RDARRaadr Inc (PK)
US$ 0,00125
(-10,71%)
169,44M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock